Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

873628

registered interest
date	28/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Spondyloarthritis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure the monitoring of individual Quality Statement measures in the NICE Quality Standard on Spondyloarthritis, to be published in June 2018.
tabling member constituency	Stafford
tabling member printed	Jeremy Lefroy
uin	134742
answer	answer is ministerial correction date of answer 17/04/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) quality standards are concise sets of statements designed to drive quality improvements within a particular area of care and cover the National Health Service, public health and social care. They are derived from the best available evidence, normally NICE guidance but also other sources of NICE-accredited guidance, and are developed by NICE in collaboration with health and social care professionals, their partners and service users. The Department does not have any arrangements for monitoring the uptake of NICE quality standards centrally as they are not mandatory, although health and care commissioners are expected to take them fully into account.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/04/2018 14:04:58 answering member 4067 label Biography information for Steve Brine
tabling member	4109 label Biography information for Jeremy Lefroy

873629

registered interest
date	28/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Arthritis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timetable is for the publication of the Rheumatoid and Early Inflammatory Arthritis Annual Report; and whether that report will include additional data collection for spondyloarthritis patients.
tabling member constituency	Stafford
tabling member printed	Jeremy Lefroy
uin	134743
answer	answer is ministerial correction date of answer 17/04/2018 answer text <p>In August 2017, a new three year Rheumatoid and Early Inflammatory Arthritis Audit was commissioned by the Healthcare Quality Improvement Partnership (HQIP). HQIP manages the National Clinical Audit and Patient Outcomes Programme on behalf of NHS England.</p><p> </p><p>The British Society for Rheumatology was awarded the contract to run the audit, which will assess the care provided by rheumatology services in England and Wales, and the health outcomes this achieves for people living with inflammatory arthritis conditions, including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.</p><p> </p><p>Building on the previous audit, which ran from 2014-16, it will provide more focused and precise data and employ real-time feedback to support local quality improvement. The audit is expected to launch in May this year, with first reports expected in the autumn of 2019. More information can be found at the following link:</p><p> </p><p><a href="http://www.rheumatology.org.uk/Knowledge/Excellence/Audits" target="_blank">www.rheumatology.org.uk/Knowledge/Excellence/Audits</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 17/04/2018 13:59:58 answering member 4067 label Biography information for Steve Brine
tabling member	4109 label Biography information for Jeremy Lefroy

867044

registered interest
date	19/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Pharmaceutical Price Regulation Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on negotiating a new Pharmaceutical Price Regulation Scheme.
tabling member constituency	Stafford
tabling member printed	Jeremy Lefroy
uin	133162
answer	answer is ministerial correction date of answer 27/03/2018 answer text <p>Informal discussions have already begun with industry regarding future medicines pricing arrangements. Formal negotiations will begin during 2018.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/03/2018 11:48:24 answering member 4067 label Biography information for Steve Brine
tabling member	4109 label Biography information for Jeremy Lefroy

838969

registered interest
date	08/02/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Surgical Mesh Implants
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will immediately suspend the use of medical procedures involving vaginal mesh implants.
tabling member constituency	Stafford
tabling member printed	Jeremy Lefroy
uin	127530
answer	answer is ministerial correction date of answer 26/02/2018 answer text <p>The Government does not support a suspension or ban of the use of surgical mesh devices. The view of the Medicines and Healthcare products Regulatory Agency (MHRA) is that surgical mesh devices are acceptably safe when used as intended and as part of an appropriate treatment pathway where the associated risk and benefits are considered, and where surgical mesh devices conform to the requirements of the current legislation in the European Union.</p><p> </p><p>As a Department we are committed to improving the outcomes for all patients involved. We continue to work closely with MHRA, NHS England, the National Institute for Health and Care Excellence and professional bodies. MHRA continue to review available evidence to ensure our regulatory position is up to date, liaising with EU partners and non-EU regulators.</p><p> </p><p> </p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 26/02/2018 16:17:21 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4109 label Biography information for Jeremy Lefroy

833993

registered interest
date	30/01/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Social Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when his Department plans to publish its consultation on adult social care.
tabling member constituency	Stafford
tabling member printed	Jeremy Lefroy
uin	125750
answer	answer is ministerial correction date of answer 07/02/2018 answer text <p>The Government has committed to publishing a Green Paper by summer 2018, setting out its proposals for reform.</p><p> </p><p>In developing the Green Paper, it is right that we take the time needed to debate the many complex issues and listen to the perspectives of experts and care users, building consensus around reforms which can succeed. This is why we are starting a process of initial engagement over the coming months through which the Government will work with experts, stakeholders and users to shape the long-term reforms that will be proposed in the Green Paper.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 07/02/2018 14:20:13 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4109 label Biography information for Jeremy Lefroy